Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis
- 11 August 2016
- journal article
- research article
- Published by Informa UK Limited in Autoimmunity
- Vol. 49 (7), 472-479
- https://doi.org/10.1080/08916934.2016.1214823
Abstract
An integrated understanding of therapeutic plasma exchange (TPE) effects on immunoglobulins, autoantibodies, and natural or acquired (vaccine) protective antibodies in patients with autoimmune myasthenia gravis (MG) is lacking. Prior studies measured TPE effects in healthy volunteers or heterogeneous autoimmune diseases populations. We prospectively profiled plasma IgA, IgM, IgG, IgG subclasses (IgG1-4), acetylcholine receptor autoantibodies (AChR+), and protective antibodies in patients with AChR+ MG receiving TPE for an exacerbation. TPE was performed according to institutional practice and patients were profiled for up to 12 weeks. Ten patients were enrolled (median age=72.9 years; baseline MG-Composite=21; median TPE treatments=6 during their first course) and all improved. The maximum decrease in all immunoglobulins, including AChR autoantibodies, was achieved on the final day of the first TPE course (approximately 60–70% reduction). Three weeks post-TPE mean AChR autoantibody, total IgG, IgG1 and IgG2 titers were below the reference range and had not recovered to within 20% of baseline, whereas other measured immunoglobulins approached baseline values. We did not generally observe an “overshoot” of immunoglobulins above pre-TPE levels or accelerated recovery of pathologic AChR autoantibodies. Protective antibody profiles showed similar patterns as other IgGs and were detectable at levels associated with protection from infection. A slow return to baseline for IgGs (except IgG3) was observed, and we did not observe any obvious effect of concomitant medications on this recovery. Collectively, these findings enhance our understanding of the immunological effects of TPE and further supports the concept of rapid immunoglobulin depletion for the treatment of patients with MG.Keywords
This publication has 19 references indexed in Scilit:
- Comparison of IVIg and PLEX in patients with myasthenia gravisNeurology, 2011
- The MG CompositeNeurology, 2010
- Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravisAutoimmunity, 2010
- Therapeutic Plasma Exchange: Core Curriculum 2008American Journal of Kidney Diseases, 2008
- Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravisEuropean Journal of Immunology, 2007
- Myasthenia gravis: past, present, and futureJCI Insight, 2006
- Immunologic reboundJournal of Clinical Apheresis, 1995
- Changes in coagulation factors, complement, immunoglobulins, and immune complex concentrations with plasma exchangeTransfusion, 1982
- Plasmapheresis in Refractory Generalized Myasthenia GravisArchives of Neurology, 1981
- The Immune GlobulinsAnnual Review of Microbiology, 1965